Telomere length and skin cancer risk: A systematic review and meta‑analysis of melanoma, basal cell carcinoma and squamous cell carcinoma
- Authors:
- Dimitrios A. Andreikos
- Demetrios A. Spandidos
-
Affiliations: School of Medicine, Democritus University of Thrace, 68100 Alexandroupoli, Greece, Laboratory of Clinical Virology, School of Medicine, University of Crete, 71003 Heraklion, Greece - Published online on: June 12, 2025 https://doi.org/10.3892/ol.2025.15141
- Article Number: 395
-
Copyright: © Andreikos et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Apalla Z, Nashan D, Weller RB and Castellsagué X: Skin cancer: Epidemiology, disease burden, pathophysiology, diagnosis, and therapeutic approaches. Dermatol Ther (Heidelb). 7 (Suppl 1):S5–S19. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Lomas A, Leonardi-Bee J and Bath-Hextall F: A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol. 166:1069–1080. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Smith H, Wernham A and Patel A: When to suspect a non-melanoma skin cancer. BMJ. 368:m6922020. View Article : Google Scholar : PubMed/NCBI | |
|
Grabowski J, Saltzstein SL, Sadler GR, Tahir Z and Blair S: A Comparison of merkel cell carcinoma and melanoma: Results from the California cancer registry. Clin Med Oncol. 2:327–333. 2008.PubMed/NCBI | |
|
Yanofsky VR, Mercer SE and Phelps RG: Histopathological variants of cutaneous squamous cell carcinoma: A review. J Skin Cancer. 2011:2108132011. View Article : Google Scholar : PubMed/NCBI | |
|
Wong CSM: Basal cell carcinoma. BMJ. 327:794–798. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Peterson SC, Eberl M, Vagnozzi AN, Belkadi A, Veniaminova NA, Verhaegen ME, Bichakjian CK, Ward NL, Dlugosz AA and Wong SY: Basal cell carcinoma preferentially arises from stem cells within hair follicle and mechanosensory niches. Cell Stem Cell. 16:400–412. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Kim RH and Armstrong AW: Nonmelanoma skin cancer. Dermatol Clin. 30:125–139. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Motley R, Kersey P and Lawrence C; British Association of Dermatologists; British Association of Plastic Surgeons; Royal College of Radiologists, Faculty of Clinical Oncology, : Multiprofessional guidelines for the management of the patient with primary cutaneous squamous cell carcinoma. Br J Dermatol. 146:18–25. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Preston DS and Stern RS: Nonmelanoma cancers of the Skin. N Engl J Med. 327:1649–1662. 1992. View Article : Google Scholar : PubMed/NCBI | |
|
Miller DL and Weinstock MA: Nonmelanoma skin cancer in the United States: Incidence. J Am Acad Dermatol. 30:774–778. 1994. View Article : Google Scholar : PubMed/NCBI | |
|
Gloster HM and Brodland DG: The epidemiology of skin cancer. Dermatol Surg. 22:217–326. 1996. View Article : Google Scholar : PubMed/NCBI | |
|
Revenga Arranz F, Paricio Rubio J, Mar Vázquez Salvado M and Del Villar Sordo V: Descriptive epidemiology of basal cell carcinoma and cutaneous squamous cell carcinoma in Soria (north-eastern Spain) 1998–2000: A hospital-based survey. J Eur Acad Dermatol Venereol. 18:137–141. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
De Vries E, Trakatelli M, Kalabalikis D, Ferrandiz L, Ruiz-de-Casas A, Moreno-Ramirez D, Sotiriadis D, Ioannides D, Aquilina S, Apap C, et al: Known and potential new risk factors for skin cancer in European populations: A multicentre case-control study: Risk factors for skin cancer in European populations. Br J Dermatol. 167 (Suppl 2):S1–S13. 2012. View Article : Google Scholar | |
|
Fargnoli MC, Piccioni A, Neri L, Tambone S, Pellegrini C and Peris K: Long-term efficacy and safety of daylight photodynamic therapy with methyl amninolevulinate for actinic keratosis of the face and scalp. Eur J Dermatol. 27:89–91. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Alam M and Ratner D: Cutaneous Squamous-cell carcinoma. N Engl J Med. 344:975–983. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Braeuer RR, Watson IR, Wu C, Mobley AK, Kamiya T, Shoshan E and Bar-Eli M: Why is melanoma so metastatic? Pigment Cell Melanoma Res. 27:19–36. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Cust AE, Armstrong BK, Goumas C, Jenkins MA, Schmid H, Hopper JL, Kefford RF, Giles GG, Aitken JF and Mann GJ: Sunbed use during adolescence and early adulthood is associated with increased risk of early-onset melanoma. Int J Cancer. 128:2425–2435. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Arnold M, De Vries E, Whiteman DC, Jemal A, Bray F, Parkin DM and Soerjomataram I: Global burden of cutaneous melanoma attributable to ultraviolet radiation in 2012. Int J Cancer. 143:1305–1314. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Elder DE, Bastian BC, Cree IA, Massi D and Scolyer RA: The 2018 World Health Organization classification of cutaneous, mucosal, and uveal melanoma: Detailed analysis of 9 distinct subtypes defined by their evolutionary pathway. Arch Pathol Lab Med. 144:500–522. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Gandini S, Sera F, Cattaruzza MS, Pasquini P, Picconi O, Boyle P and Melchi CF: Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. Eur J Cancer. 41:45–60. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Rastrelli M, Tropea S, Rossi CR and Alaibac M: Melanoma: Epidemiology, risk factors, pathogenesis, diagnosis and classification. In Vivo. 28:1005–1011. 2014.PubMed/NCBI | |
|
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E86. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Chang C, Murzaku EC, Penn L, Abbasi NR, Davis PD, Berwick M and Polsky D: More skin, more sun, more tan, more melanoma. Am J Public Health. 104:e92–e99. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Leonardi GC, Falzone L, Salemi R, Zanghï A, Spandidos DA, Mccubrey JA, Candido S and Libra M: Cutaneous melanoma: From pathogenesis to therapy (Review). Int J Oncol. 52:1071–1080. 2018.PubMed/NCBI | |
|
Blackburn EH, Epel ES and Lin J: Human telomere biology: A contributory and interactive factor in aging, disease risks, and protection. Science. 350:1193–1198. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Moon IK and Jarstfer MB: The human telomere and its relationship to human disease, therapy, and tissue engineering. Front Biosci J Virtual Libr. 12:4595–4620. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
O'Sullivan RJ and Karlseder J: Telomeres: Protecting chromosomes against genome instability. Nat Rev Mol Cell Biol. 11:171–1781. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
De Lange T: How telomeres solve the End-protection problem. Science. 326:948–952. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Monaghan P and Haussmann MF: Do telomere dynamics link lifestyle and lifespan? Trends Ecol Evol. 21:47–53. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Shay JW and Wright WE: Hayflick, his limit, and cellular ageing. Nat Rev Mol Cell Biol. 1:72–76. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Shay JW and Wright WE: Role of telomeres and telomerase in cancer. Semin Cancer Biol. 21:349–353. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Artandi SE and DePinho RA: Telomeres and telomerase in cancer. Carcinogenesis. 31:9–18. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Shay JW and Bacchetti S: A survey of telomerase activity in human cancer. Eur J Cancer. 33:787–791. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Maciejowski J and de Lange T: Telomeres in cancer: Tumour suppression and genome instability. Nat Rev Mol Cell Biol. 18:175–186. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Robinson NJ and Schiemann WP: Telomerase in cancer: Function, regulation, and clinical translation. Cancers. 14:8082022. View Article : Google Scholar : PubMed/NCBI | |
|
Xu Y and Goldkorn A: Telomere and telomerase therapeutics in cancer. Genes. 7:222016. View Article : Google Scholar : PubMed/NCBI | |
|
Dratwa M, Wysoczańska B, Łacina P, Kubik T and Bogunia-Kubik K: TERT-Regulation and roles in cancer formation. Front Immunol. 11:5899292020. View Article : Google Scholar : PubMed/NCBI | |
|
Tsatsakis A, Oikonomopoulou T, Nikolouzakis TK, Vakonaki E, Tzatzarakis M, Flamourakis M, Renieri E, Fragkiadaki P, Iliaki E, Bachlitzanaki M, et al: Role of telomere length in human carcinogenesis (Review). Int J Oncol. 63:782023. View Article : Google Scholar : PubMed/NCBI | |
|
López-Otín C, Pietrocola F, Roiz-Valle D, Galluzzi L and Kroemer G: Meta-hallmarks of aging and cancer. Cell Metab. 35:12–35. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Hanahan D and Weinberg RA: Hallmarks of cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Okamoto K and Seimiya H: Revisiting telomere shortening in cancer. Cells. 8:1072019. View Article : Google Scholar : PubMed/NCBI | |
|
Andreikos D, Kyrodimos E, Kotsinas A, Chrysovergis A and Papacharalampous GX: The Association between telomere length and head and neck cancer risk: A systematic review and Meta-analysis. Int J Mol Sci. 25:90002024. View Article : Google Scholar : PubMed/NCBI | |
|
Karimi B, Yunesian M, Nabizadeh R, Mehdipour P and Aghaie A: Is leukocyte telomere length related with lung cancer risk?: A Meta-Analysis. Iran Biomed J. 21:142–153. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Ma H, Zhou Z, Wei S, Liu Z, Pooley KA, Dunning AM, Svenson U, Roos G, Hosgood HD III, Shen M and Wei Q: Shortened telomere length is associated with increased risk of cancer: A meta-analysis. PLoS One. 6:e204662011. View Article : Google Scholar : PubMed/NCBI | |
|
Zhu X, Han W, Xue W, Zou Y, Xie C, Du J and Jin G: The association between telomere length and cancer risk in population studies. Sci Rep. 6:222432016. View Article : Google Scholar : PubMed/NCBI | |
|
Benites-Zapata VA, Ulloque-Badaracco JR, Alarcón-Braga EA, Fernández-Alonso AM, López-Baena MT and Pérez-López FR: Telomerase activity and telomere length in women with breast cancer or without malignancy: A systematic review and meta-analysis. Maturitas. 180:1078822024. View Article : Google Scholar : PubMed/NCBI | |
|
Naing C, Aung K, Lai PK and Mak JW: Association between telomere length and the risk of colorectal cancer: A meta-analysis of observational studies. BMC Cancer. 17:242017. View Article : Google Scholar : PubMed/NCBI | |
|
Caini S, Raimondi S, Johansson H, De Giorgi V, Zanna I, Palli D and Gandini S: Telomere length and the risk of cutaneous melanoma and non-melanoma skin cancer: A review of the literature and meta-analysis. J Dermatol Sci. 80:168–174. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Rode L, Nordestgaard BG and Bojesen SE: Long telomeres and cancer risk among 95 568 individuals from the general population. Int J Epidemiol. 45:1634–1643. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Fabiani R, Chiavarini M, Rosignoli P and Giacchetta I: Leucocyte telomere length and lung cancer risk: A systematic review and Meta-analysis of prospective studies. Cancers (Basel). 16:32182024. View Article : Google Scholar : PubMed/NCBI | |
|
Chen S, Hu S, Zhou B, Cheng B, Tong H, Su D, Li X, Chen Y and Zhang G: Telomere-related prognostic biomarkers for survival assessments in pancreatic cancer. Sci Rep. 13:105862023. View Article : Google Scholar : PubMed/NCBI | |
|
Holesova Z, Krasnicanova L, Saade R, Pös O, Budis J, Gazdarica J, Repiska V and Szemes T: Telomere length changes in cancer: Insights on carcinogenesis and potential for Non-invasive diagnostic strategies. Genes (Basel). 14:7152023. View Article : Google Scholar : PubMed/NCBI | |
|
Wentzensen IM, Mirabello L, Pfeiffer RM and Savage SA: The association of telomere length and cancer: A meta-analysis. Cancer Epidemiol Biomarkers Prev. 20:1238–1250. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, et al: The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ. 372:n712021. View Article : Google Scholar : PubMed/NCBI | |
|
Higgins JPT: Measuring inconsistency in meta-analyses. BMJ. 327:557–560. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Green S and Higgins JPT: Cochrane Handbook for Systematic Reviews of Interventions. The Cochrane Collaboration. http://training.cochrane.org/handbookMarch 20–2025 | |
|
DerSimonian R and Laird N: Meta-analysis in clinical trials. Control Clin Trials. 7:177–188. 1986. View Article : Google Scholar : PubMed/NCBI | |
|
Egger M, Smith GD, Schneider M and Minder C: Bias in meta-analysis detected by a simple, graphical test. BMJ. 315:629–634. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Sterne JAC, Gavaghan D and Egger M: Publication and related bias in meta-analysis. J Clin Epidemiol. 53:1119–1129. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M and Tugwell P: The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses. 2013. http://www.ohri.ca/programs/clinical_epidemiology/oxford.aspMarch 20–2025 | |
|
Han J, Qureshi AA, Prescott J, Guo Q, Ye L, Hunter DJ and De Vivo I: A Prospective study of telomere length and the risk of skin cancer. J Invest Dermatol. 129:415–421. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Nan H, Du M, De Vivo I, Manson JE, Liu S, McTiernan A, Curb JD, Lessin LS, Bonner MR, Guo Q, et al: Shorter telomeres associate with a reduced risk of melanoma development. Cancer Res. 71:6758–6763. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Weischer M: Short telomere length, cancer survival, and cancer risk in 47102 individuals. J Natl Cancer Inst. 105:459–468. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Greenland S, Thomas DC and Morgenstern H: The rare-disease assumption revisited. Am J Epidemiol. 124:869–876. 1986. View Article : Google Scholar : PubMed/NCBI | |
|
Anic GM, Sondak VK, Messina JL, Fenske NA, Zager JS, Cherpelis BS, Lee JH, Fulp WJ, Epling-Burnette PK, Park JY and Rollison DE: Telomere length and risk of melanoma, squamous cell carcinoma, and basal cell carcinoma. Cancer Epidemiol. 37:434–439. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Rachakonda S, Kong H, Srinivas N, Garcia-Casado Z, Requena C, Fallah M, Heidenreich B, Planelles D, Traves V, Schadendorf D, et al: Telomere length, telomerase reverse transcriptase promoter mutations, and melanoma risk. Genes Chromosomes Cancer. 57:564–572. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Schneider CV, Schneider KM, Teumer A, Rudolph KL, Hartmann D, Rader DJ and Strnad P: Association of telomere length with risk of disease and mortality. JAMA Intern Med. 182:291–300. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Bodelon C, Pfeiffer RM, Bollati V, Debbache J, Calista D, Ghiorzo P, Fargnoli MC, Bianchi-Scarra G, Peris K, Hoxha M, et al: On the interplay of telomeres, nevi and the risk of melanoma. PLoS One. 7:e524662012. View Article : Google Scholar : PubMed/NCBI | |
|
Llorca-Cardeñosa MJ, Peña-Chilet M, Mayor M, Gomez-Fernandez C, Casado B, Martin-Gonzalez M, Carretero G, Lluch A, Martinez-Cadenas C, Ibarrola-Villava M and Ribas G: Long telomere length and a TERT-CLPTM1 locus polymorphism association with melanoma risk. Eur J Cancer. 50:3168–3177. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Menin C, Bojnik E, Del Bianco P, Elefanti L, Gianesin K, Keppel S, Stagni C, Mocellin S, Vecchiato A and De Rossi A: Differences in telomere length between sporadic and familial cutaneous melanoma. Br J Dermatol. 175:937–943. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Burke LS, Hyland PL, Pfeiffer RM, Prescott J, Wheeler W, Mirabello L, Savage SA, Burdette L, Yeager M, Chanock S, et al: Telomere length and the risk of cutaneous malignant melanoma in Melanoma-Prone families with and without CDKN2A mutations. PLoS One. 8:e711212013. View Article : Google Scholar : PubMed/NCBI | |
|
Perrem K, Lynch A, Al Nooh F, Leader M and Elaine Kay: The different telomere lengths in basal and squamous cell carcinomas also differ between the nontransplant and renal transplant population. Hum Pathol. 39:1034–1041. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Srinivas N, Rachakonda S, Hielscher T, Calderazzo S, Rudnai P, Gurzau E, Koppova K, Fletcher T and Kumar R: Telomere length, arsenic exposure and risk of basal cell carcinoma of skin. Carcinogenesis. 40:715–723. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Liang G, Qureshi AA, Guo Q, De Vivo I and Han J: No association between telomere length in peripheral blood leukocytes and the risk of nonmelanoma skin cancer. Cancer Epidemiol Biomarkers Prev. 20:1043–1045. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Wainwright LJ, Rees JL and Middleton PG: Changes in mean telomere length in basal cell carcinomas of the skin. Genes Chromosomes Cancer. 12:45–49. 1995. View Article : Google Scholar : PubMed/NCBI | |
|
Perrem K, Lynch A, Conneely M, Wahlberg H, Murphy G, Leader M and Kay E: The higher incidence of squamous cell carcinoma in renal transplant recipients is associated with increased telomere lengths. Hum Pathol. 38:351–358. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
De Vitis M, Berardinelli F and Sgura A: Telomere length maintenance in cancer: At the crossroad between telomerase and alternative lengthening of telomeres (ALT). Int J Mol Sci. 19:6062018. View Article : Google Scholar : PubMed/NCBI | |
|
Andreikos D, Spandidos D and Georgakopoulou V: Telomeres and telomerase in mesothelioma: Pathophysiology, biomarkers and emerging therapeutic strategies (Review). Int J Oncol. 66:232025. View Article : Google Scholar : PubMed/NCBI | |
|
Mooi WJ and Peeper DS: Oncogene-induced cell Senescence-halting on the road to cancer. N Engl J Med. 355:1037–1046. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Gray-Schopfer VC, Cheong SC, Chong H, Chow J, Moss T, Abdel-Malek ZA, Marais R, Wynford-Thomas D and Bennett DC: Cellular senescence in naevi and immortalisation in melanoma: A role for p16? Br J Cancer. 95:496–505. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Bataille V, Kato BS, Falchi M, Gardner J, Kimura M, Lens M, Perks U, Valdes AM, Bennett DC, Aviv A and Spector TD: Nevus size and number are associated with telomere length and represent potential markers of a decreased senescence in vivo. Cancer Epidemiol Biomarkers Prev. 16:1499–1502. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Robles-Espinoza CD, Velasco-Herrera M del C, Hayward NK and Adams DJ: Telomere-regulating genes and the telomere interactome in familial cancers. Mol Cancer Res. 13:211–222. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Toussi A, Mans N, Welborn J and Kiuru M: Germline mutations predisposing to melanoma. J Cutan Pathol. 47:606–616. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Son N, Cui Y and Xi W: Association between telomere length and skin cancer and aging: A mendelian randomization analysis. Front Genet. 13:9317852022. View Article : Google Scholar : PubMed/NCBI | |
|
McNally EJ, Luncsford PJ and Armanios M: Long telomeres and cancer risk: The price of cellular immortality. J Clin Invest. 129:3474–3481. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Stanley SE and Armanios M: The short and long telomere syndromes: Paired paradigms for molecular medicine. Curr Opin Genet Dev. 33:1–9. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Barrett ELB, Burke TA, Hammers M, Komdeur J and Richardson DS: Telomere length and dynamics predict mortality in a wild longitudinal study. Mol Ecol. 22:249–259. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Speedy HE, Di Bernardo MC, Sava GP, Dyer MJS, Holroyd A, Wang Y, Sunter NJ, Mansouri L, Juliusson G, Smedby KE, et al: A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia. Nat Genet. 46:56–60. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Rachakonda S, Srinivas N, Mahmoudpour SH, Garcia-Casado Z, Requena C, Traves V, Soriano V, Cardelli M, Pjanova D, Molven A, et al: Telomere length and survival in primary cutaneous melanoma patients. Sci Rep. 8:109472018. View Article : Google Scholar : PubMed/NCBI | |
|
Martinez-Delgado B, Yanowsky K, Inglada-Perez L, De La Hoya M, Caldes T, Vega A, Blanco A, Martin T, Gonzalez-Sarmiento R, Blasco M, et al: Shorter telomere length is associated with increased ovarian cancer risk in both familial and sporadic cases. J Med Genet. 49:341–344. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Martinez-Delgado B, Yanowsky K, Inglada-Perez L, Domingo S, Urioste M, Osorio A and Benitez J: Genetic anticipation is associated with telomere shortening in hereditary breast cancer. PLoS Genet. 7:e10021822011. View Article : Google Scholar : PubMed/NCBI | |
|
Rossi M, Pellegrini C, Cardelli L, Ciciarelli V, Di Nardo L and Fargnoli MC: Familial melanoma: Diagnostic and management implications. Dermatol Pract Concept. 9:10–16. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Zocchi L, Lontano A, Merli M, Dika E, Nagore E, Quaglino P, Puig S and Ribero S: Familial Melanoma and susceptibility genes: A review of the most common clinical and dermoscopic phenotypic aspect, associated malignancies and practical tips for management. J Clin Med. 10:37602021. View Article : Google Scholar : PubMed/NCBI | |
|
Hansen MEB, Hunt SC, Stone RC, Horvath K, Herbig U, Ranciaro A, Hirbo J, Beggs W, Reiner AP, Wilson JG, et al: Shorter telomere length in Europeans than in Africans due to polygenetic adaptation. Hum Mol Genet. 25:2324–2330. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Chang YM, Barrett JH, Bishop DT, Armstrong BK, Bataille V, Bergman W, Berwick M, Bracci PM, Elwood JM, Ernstoff MS, et al: Sun exposure and melanoma risk at different latitudes: A pooled analysis of 5700 cases and 7216 controls. Int J Epidemiol. 38:814–830. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Armstrong BK and Kricker A: The epidemiology of UV induced skin cancer. J Photochem Photobiol B. 63:8–18. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Lundsgaard NU, Cramp RL and Franklin CE: Early exposure to UV radiation causes telomere shortening and poorer condition later in life. J Exp Biol. 225:jeb2439242022. View Article : Google Scholar : PubMed/NCBI | |
|
Gardner M, Bann D, Wiley L, Cooper R, Hardy R, Nitsch D, Martin-Ruiz C, Shiels P, Sayer AA, Barbieri M, et al: Gender and telomere length: Systematic review and meta-analysis. Exp Gerontol. 51:15–27. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Kyo S, Takakura M, Kanaya T, Zhuo W, Fujimoto K, Nishio Y, Orimo A and Inoue M: Estrogen activates telomerase. Cancer Res. 59:5917–5921. 1999.PubMed/NCBI | |
|
Ventura A, Pellegrini C, Cardelli L, Rocco T, Ciciarelli V, Peris K and Fargnoli MC: Telomeres and telomerase in cutaneous squamous cell carcinoma. Int J Mol Sci. 20:13332019. View Article : Google Scholar : PubMed/NCBI | |
|
Gilchrest BA, Eller MS, Geller AC and Yaar M: The pathogenesis of melanoma induced by ultraviolet radiation. N Engl J Med. 340:1341–1348. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Yamada-Hishida H, Nobeyama Y and Nakagawa H: Correlation of telomere length to malignancy potential in non-melanoma skin cancers. Oncol Lett. 15:393–399. 2018.PubMed/NCBI | |
|
Grimes DA and Schulz KF: Bias and causal associations in observational research. Lancet. 359:248–252. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Glasziou PP and Sanders SL: Investigating causes of heterogeneity in systematic reviews. Stat Med. 21:1503–1511. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Montpetit AJ, Alhareeri AA, Montpetit M, Starkweather AR, Elmore LW, Filler K, Mohanraj L, Burton CW, Menzies VS, Lyon DE and Jackson-Cook CK: Telomere length: A review of methods for measurement. Nurs Res. 63:289–299. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Gutierrez-Rodrigues F, Santana-Lemos BA, Scheucher PS, Alves-Paiva RM and Calado RT: Direct comparison of Flow-FISH and qPCR as diagnostic tests for telomere length measurement in humans. PLoS One. 9:e1137472014. View Article : Google Scholar : PubMed/NCBI | |
|
Lin L: Bias caused by sampling error in meta-analysis with small sample sizes. PLoS One. 13:e02040562018. View Article : Google Scholar : PubMed/NCBI |
